Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The 1/4/6x24 campaign to cure tuberculosis quickly

Nature Medicine volume 29, pages 16–17 (2023)Cite this article

Subjects

The “right of everyone to enjoy the benefits of scientific progress and its applications,” also known as the right to science, is enshrined in the Universal Declaration of Human Rights and international human rights law. People with and at risk of tuberculosis (TB) are eager to realize this right1,2. Among the essential “applications of scientific progress” are the long-awaited shorter, less toxic TB treatment regimens. Thanks to two decades of renewed investments in TB drug development and research, it is now possible to treat TB infection in as little as one month and most forms of drug-sensitive and drug-resistant TB in four and six months, respectively3,4,5,6,7,8. However, these shorter treatments are futile until they reach the people who need them. Thus the 1/4/6x24 (one, four, six by 2024) campaign was launched at the AIDS 2022 conference in Montreal (see Table 1).

Table 1 The 1/4/6x24 campaign
Full size table

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. United Nations General Assembly. Universal Declaration of Human Rights 217 A (III); https://go.nature.com/3jFTm4p (1948).

  2. United Nations General Assembly. International Covenant on Economic, Social and Cultural Rights 2200A (XXI); https://go.nature.com/3ImjL1A (1966).

  3. Swindells, S. et al. N. Engl. J. Med. 380, 1001–1011 (2019).

    Article  CAS  Google Scholar 

  4. Sterling, T. R. et al. N. Engl. J. Med. 365, 2155–2166 (2011).

    Article  CAS  Google Scholar 

  5. Dorman, S. E. et al. N. Engl. J. Med. 384, 1705–1718 (2021).

    Article  CAS  Google Scholar 

  6. Turkova, A. et al. N. Engl. J. Med. 386, 911–922 (2022).

    Article  CAS  Google Scholar 

  7. Conradie, F. et al. N. Engl. J. Med. 387, 810–823 (2022).

    Article  CAS  Google Scholar 

  8. Nyang’wa, B. T. et al. N. Engl. J. Med. 387, 2331–2343 (2022).

  9. Farmer, P. Am. J. Pub. Health 89, 1486–1496 (1999).

    Article  CAS  Google Scholar 

  10. Farmer, P. E. N. Engl. J. Med. 369, 2424–2436 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Treatment Action Group, New York, NY, USA

    Lindsay McKenna, Mike Frick & Mark Harrington

  2. Access to Rights and Knowledge Foundation, Kohima, Nagaland, India

    Ketholelie Angami

  3. Africa Centre for HIV/AIDS Management, Stellenbosch University, Stellenbosch, South Africa

    Vuyiseka Dubula

  4. Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA

    Jennifer Furin & Carole D. Mitnick

  5. TB HIV Care, Cape Town, South Africa

    Harry Hausler

  6. Department of Family Medicine, School of Medicine, University of Pretoria, Pretoria, South Africa

    Harry Hausler

  7. TB PPM Learning Network, Research Institute of the McGill University Health Centre, Quebec, Canada

    Petra Heitkamp

  8. National Tuberculosis Social Observatory, Mexicali, Mexico

    Rosa Herrera

  9. Global Health Policy and Politics Initiative, O’Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA

    Sharonann Lynch

  10. Partners In Health, Boston, MA, USA

    Carole D. Mitnick, Lindsay Palazuelos & Patrick Ulysse

  11. National Empowerment Network of People Living with HIV/AIDS in Kenya, Nairobi, Kenya

    Gloriah Kerubo Moses

  12. TB Control and Management, National Department of Health, Pretoria, South Africa

    Norbert Ndjeka

  13. Operational Centre Amsterdam, Médecins Sans Frontières, Amsterdam, the Netherlands

    Bern-Thomas Nyang’wa

  14. McGill International TB Centre, McGill University, Montreal, Quebec, Canada

    Madhukar Pai

Authors
  1. Lindsay McKenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mike Frick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ketholelie Angami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vuyiseka Dubula
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer Furin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark Harrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Harry Hausler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Petra Heitkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rosa Herrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sharonann Lynch
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Carole D. Mitnick
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gloriah Kerubo Moses
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Norbert Ndjeka
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Bern-Thomas Nyang’wa
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Lindsay Palazuelos
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Patrick Ulysse
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Madhukar Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lindsay McKenna.

Ethics declarations

Competing interests

J.F. received grant funding from the Stop TB Partnership’s Global Drug Facility to support the rollout of child-friendly formulations of second-line drugs. M.P. has no financial or industry conflicts to disclose; he serves as an advisor to the WHO, Foundation for Innovative New Diagnostics, Stop TB Partnership and Bill & Melinda Gates Foundation. B.-T.N. is employed by Médecins Sans Frontières, the sponsor of the TB-PRACTECAL trial that developed a 6-month multidrug-resistant/rifampicin-resistant TB (RR-/MDR-TB) regimen. Through grants to her institution, C.D.M. receives research funding to study all-oral shortened regimens for treatment of drug-resistant TB containing bedaquiline, delamanid, linezolid, clofazimine, levofloxacin, moxifloxacin and pyrazinamide.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McKenna, L., Frick, M., Angami, K. et al. The 1/4/6x24 campaign to cure tuberculosis quickly. Nat Med 29, 16–17 (2023). https://doi.org/10.1038/s41591-022-02136-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-02136-z

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing